Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS)
A Phase 2a, Open-Label, Single-Arm Study to Investigate the Safety and Efficacy of ATI-450 for the Maintenance of Remission in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS) Previously Managed With Anti-IL-1 Therapy A Phase 2a, Open-Label, Single-Arm Study to Investigate the Safety and Efficacy of ATI-450for the Ma ...